ACCESSION: MSBNK-SMB_Measured-HSA015P0268000
RECORD_TITLE: Annotated; Adenosine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'EL20_pos_2457': {'bp': 7910124.0, 'sum': 9146111.0}, 'EL19_pos_2487': {'bp': 4712008.0, 'sum': 5462029.0}, 'EL16_pos_2445': {'bp': 4609998.0, 'sum': 5328205.0}, 'EL18_pos_2469': {'bp': 4021522.0, 'sum': 4677647.0}, 'EL01_pos_2469': {'bp': 3257060.0, 'sum': 3785951.0}, 'EL06_pos_2469': {'bp': 3103982.0, 'sum': 3627276.0}, 'EL22_pos_2481': {'bp': 2876634.0, 'sum': 3364323.0}, 'EL02_pos_2457': {'bp': 2760695.0, 'sum': 3203226.0}, 'EL09_pos_2445': {'bp': 2263520.0, 'sum': 2648965.0}, 'EL07_pos_2469': {'bp': 2159062.0, 'sum': 2521009.0}, 'EL04_pos_2499': {'bp': 2130872.0, 'sum': 2481641.0}, 'EL17_pos_2459': {'bp': 2006000.0, 'sum': 2342672.0}, 'EL23_pos_2477': {'bp': 1729773.0, 'sum': 2027350.0}, 'EL08_pos_2470': {'bp': 1679852.0, 'sum': 1963542.0}, 'EL13_pos_2465': {'bp': 1587155.0, 'sum': 1852400.0}, 'EL24_pos_2517': {'bp': 1468019.0, 'sum': 1725349.0}, 'EL21_pos_2457': {'bp': 1342430.0, 'sum': 1609024.0}, 'EL15_pos_2441': {'bp': 1270238.0, 'sum': 1494057.0}, 'EL05_pos_2469': {'bp': 1162648.0, 'sum': 1398850.0}, 'EL03_pos_2710': {'bp': 1062826.0, 'sum': 1307778.0}, 'EL14_pos_2451': {'bp': 879641.0, 'sum': 1061277.0}, 'EL10_pos_2471': {'bp': 812104.0, 'sum': 971462.0}, 'EL12_pos_2439': {'bp': 695034.0, 'sum': 864308.0}, 'EL11_pos_2445': {'bp': 521329.0, 'sum': 646615.0}}
COMMENT: RETENTION_TIME_STDEV 0.073
COMMENT: PRECURSOR_M/Z_RAW 268.104115
COMMENT: PRECURSOR_M/Z_STDEV 0.000096
COMMENT: PRECURSOR_IN_MS1 mz 268.104117; int 175.479; delta(ppm) 1.440467
COMMENT: PROPOSED_CHARGE_STATE +1; mz 269.107822; int 20.256; cor 0.966
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.329; C10H13N5O4; [M+H]+; delta(ppm) 0.329469
COMMENT: PROPOSED_MF MS-FINDER 3.513; C10H13N5O4; [M+H]+; delta(ppm) 0.326845
COMMENT: PROPOSED_MF MS-FINDER 2.272; C11H9N9; [M+H]+; delta(ppm) -4.661546
COMMENT: PROPOSED_MF MS-FINDER 1.965; C10H21NO3S2; [M+H]+; delta(ppm) 2.073918
COMMENT: PROPOSED_MF SIRIUS5_Sirius 13.572; C10H13N5O4; [M+H]+; delta(ppm) 0.326845
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.270; C9H17NO8; [M+H]+; delta(ppm) 5.315286
COMMENT: PROPOSED_MF SIRIUS5_Sirius 9.623; C11H9N9; [M+H]+; delta(ppm) -4.661546
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.789; C10H21NO3S2; [M+H]+; delta(ppm) 2.073918
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.158; C13H12F3N3; [M+H]+; delta(ppm) -5.556903
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.667; C15H13BO4; [M+H]+; delta(ppm) 38806.267786
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.948; C10H13N5O4; [M+H]+; delta(ppm) 0.326845
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.051; C9H17NO8; [M+H]+; delta(ppm) 5.315286
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.001; C11H9N9; [M+H]+; delta(ppm) -4.661546
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.961; C10H13N5O4; [M+H]+; delta(ppm) 0.326845
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.660; C9H17NO8; [M+H]+; delta(ppm) 5.315286
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.012; C11H9N9; [M+H]+; delta(ppm) -4.661546
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.827; C7H14FN5O5; [M+H]+; delta(ppm) -3.935118
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.726; C12H15N2O5; [M+H]+; delta(ppm) -4.681127
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.922; C10H13F4N3O; [M+H]+; delta(ppm) -9.818816
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.875; C8H18N3O5P; [M+H]+; delta(ppm) -5.834036
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.690; C8H21NO5Si2; [M+H]+; delta(ppm) -192572.381656
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.206; C9H17N5OSi2; [M+H]+; delta(ppm) -192575.633785
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.170; C9H18ClN3O4; [M+H]+; delta(ppm) -82167.959499
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.991; C10H13N5O4; [M+H]+; delta(ppm) 0.326845
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.007; C9H17NO8; [M+H]+; delta(ppm) 5.315286
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C11H9N9; [M+H]+; delta(ppm) -4.661546
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 114.000; OIRDTQYFTABQOQ-UHFFFAOYSA-N; C10H13N5O4; Massbank:PB006010 Adenosine(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 74.000; OIRDTQYFTABQOQ-KQYNXXCUSA-N; C10H13N5O4; Massbank:FIO00684 Adenosine
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; OIRDTQYFTABQOQ-KBNQYOMWSA-N; C10H13N5O4; MLS002153992-01!Vidarabine5536-17-4
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; OIRDTQYFTABQOQ-UHTZMRCNSA-N; C10H13N5O4; MLS001066352-01!Adenine 9-beta;-D-arabinofuranoside
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.207; ROKFJKIUAHNTIS-CKFZYJBLNA-N; [M+H]+; NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=CN=N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.804; OIRDTQYFTABQOQ-KQYNXXCUSA-N; [M+H]+; NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.797; UGBOLVVJCMKMDN-JJEYZYPKNA-N; [M+H]+; NC1=NC=NC2=C1N(C=N2)[C@@H]1O[C@@H](CO)[C@@H](O)[C@@H]1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.664; JVOJULURLCZUDE-UHFFFAOYSA-N; [M+H]+; OCC1OC(N2C=NC=3C=NC(=NC32)N)C(O)C1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.644; DOBVUNYQLACHMP-UHFFFAOYSA-N; [M+H]+; OCC1OC(C=2C=NN3C(=NC=NC23)N)C(O)C1O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.330; OIRDTQYFTABQOQ-KQYNXXCUSA-N; [M+H]+; Adenosine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.008; YKBGVTZYEHREMT-DWFKHXNSNA-N; [M+H]+; Deoxyguanosine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.580; HBOMLICNUCNMMY-XLPZGREQSA-N; [M+H]+; Zidovudine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.504; KBHMEHLJSZMEMI-MXWFMQRVNA-N; [M+H]+; 8-Aza-9-deazaadenosine;Formycin;Formycin A;NSC 102811
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.306; FBLYADUDJIDSCH-FUEBQVTPNA-N; [M+H]+; UNPD178510
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.283; UGBOLVVJCMKMDN-JJEYZYPKNA-N; [M+H]+; UNPD97636
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.283; ROKFJKIUAHNTIS-CKFZYJBLNA-N; [M+H]+; UNPD129952
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.256; BCSLVBZWCFTDPK-UDJQAZALSA-N; [M+H]+; 2-amino-9-[(2R,3R,4S)-3,4-bis(hydroxymethyl)oxetan-2-yl]-1H-purin-6-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.251; DOBVUNYQLACHMP-UHFFFAOYSA-N; [M+H]+; 2-{4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl}-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.231; JVOJULURLCZUDE-UHFFFAOYSA-N; [M+H]+; 2-(2-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.231; OROIAVZITJBGSM-PJPYAQQDSA-N; [M+H]+; 3-Deoxyguanosine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.222; BFOWFSDEOHCFQL-UHFFFAOYSA-N; [M+H]+; 5-[6-(hydroxyamino)-9H-purin-9-yl]-2-(hydroxymethyl)oxolan-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.189; NDWAUKFSFFRGLF-YRZWDFBDSA-N; [M+H]+; 6-amino-9-[(4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-purin-8-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.183; DIRJXXLRJXTDMP-BAJZRUMYSA-N; [M+H]+; (2R,3R,5S)-2-(1-hydroxy-6-iminopurin-9-yl)-5-(hydroxymethyl)oxolan-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.172; SWFIFWZFCNRPBN-UHFFFAOYSA-N; [M+H]+; 6-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,9-dihydro-2H-purin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.050; JBGNSGHDTKKNKE-UHFFFAOYSA-N; [M+H]+; 2-[(2,4-dimethoxyphenyl)methylideneamino]-1-nitroguanidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.022; OFPUSTXYFCLHSA-JGVFFNPUSA-N; [M+H]+; 1-[(2R,5S)-5-(azidooxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.008; BXQVVDJZCDTBBB-UHFFFAOYSA-N; [M+H]+; 3-(8-amino-1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-7-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.720; AODWRCBKSKPVFN-UHFFFAOYSA-N; [M+H]+; 1-{1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}-1H-pyrazolo[3,4-d]pyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; JBGNSGHDTKKNKE-UHFFFAOYSA-N; [M+H]+; 2-[(2,4-dimethoxyphenyl)methylideneamino]-1-nitroguanidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.965; JVOJULURLCZUDE-UHFFFAOYSA-N; [M+H]+; 2-(2-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.949; OIRDTQYFTABQOQ-KQYNXXCUSA-N; [M+H]+; Adenosine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.949; UGBOLVVJCMKMDN-JJEYZYPKNA-N; [M+H]+; UNPD97636
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.947; ROKFJKIUAHNTIS-CKFZYJBLNA-N; [M+H]+; UNPD129952
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.935; DOBVUNYQLACHMP-UHFFFAOYSA-N; [M+H]+; 2-{4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl}-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.909; KBHMEHLJSZMEMI-MXWFMQRVNA-N; [M+H]+; 8-Aza-9-deazaadenosine;Formycin;Formycin A;NSC 102811
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.770; BFOWFSDEOHCFQL-UHFFFAOYSA-N; [M+H]+; 5-[6-(hydroxyamino)-9H-purin-9-yl]-2-(hydroxymethyl)oxolan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.723; YKBGVTZYEHREMT-DWFKHXNSNA-N; [M+H]+; Deoxyguanosine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.713; NDWAUKFSFFRGLF-YRZWDFBDSA-N; [M+H]+; 6-amino-9-[(4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-purin-8-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.712; DIRJXXLRJXTDMP-BAJZRUMYSA-N; [M+H]+; (2R,3R,5S)-2-(1-hydroxy-6-iminopurin-9-yl)-5-(hydroxymethyl)oxolan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.712; SWFIFWZFCNRPBN-UHFFFAOYSA-N; [M+H]+; 6-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,9-dihydro-2H-purin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.654; OROIAVZITJBGSM-PJPYAQQDSA-N; [M+H]+; 3-Deoxyguanosine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.654; FBLYADUDJIDSCH-FUEBQVTPNA-N; [M+H]+; UNPD178510
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.653; BCSLVBZWCFTDPK-UDJQAZALSA-N; [M+H]+; 2-amino-9-[(2R,3R,4S)-3,4-bis(hydroxymethyl)oxetan-2-yl]-1H-purin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.653; HBOMLICNUCNMMY-XLPZGREQSA-N; [M+H]+; Zidovudine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.647; OFPUSTXYFCLHSA-JGVFFNPUSA-N; [M+H]+; 1-[(2R,5S)-5-(azidooxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.134; BXQVVDJZCDTBBB-UHFFFAOYSA-N; [M+H]+; 3-(8-amino-1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-7-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; OIRDTQYFTABQOQ-KQYNXXCUSA-N; [M+H]+; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.105; HBOMLICNUCNMMY-XLPZGREQSA-N; [M+H]+; 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.929; YKBGVTZYEHREMT-KVQBGUIXSA-N; [M+H]+; 2-amino-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.295; KBHMEHLJSZMEMI-KSYZLYKTSA-N; [M+H]+; (2S,3R,4S,5R)-2-(7-amino-2H-pyrazolo[4,3-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; DMHAXLGAKQREIL-UHFFFAOYSA-N; [M+H]+; 2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.726; ZCGXVDFOMRHQOX-UHFFFAOYSA-N; [M+H]+; 3-amino-4-nitro-6,6-bis(prop-2-enyl)-1H-1,2,4-triazepine-5,7-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.659; HRHRHVGMNKXMNM-UHFFFAOYSA-N; [M+H]+; 2-[2-(4-nitrosopiperazin-1-yl)pyrimidin-5-yl]oxyacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.223; DJMINGJGFGSDDB-UHFFFAOYSA-N; [M+H]+; N-[9-(2-hydroxyethoxymethyl)-6-oxo-1H-purin-2-yl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -0.993; OIRDTQYFTABQOQ; [M+H]+; Adenocor
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -28.734; UGBOLVVJCMKMDN; [M+H]+; 7-pentofuranosyl-7h-purin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -106.165; NVQJZNAROPEJPJ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.448; ROKFJKIUAHNTIS; [M+H]+; 2-(4-aminoimidazo[4,5-d]pyridazin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.468; NDWAUKFSFFRGLF; [M+H]+; 8-Oxo-dado
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -184.703; JXQMTPJDEKCVMN; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -186.122; YKBGVTZYEHREMT; [M+H]+; bmse000003
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.079; OROIAVZITJBGSM; [M+H]+; 3-Deoxyguanosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.185; IVZPUWMBSKGJLT; [M+H]+; 9-D-Apio-beta-D-furanosyl-9H-purin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.593; SWFIFWZFCNRPBN; [M+H]+; Oprea1_237823
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.308; FBLYADUDJIDSCH; [M+H]+; 5''-Deoxyguanosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -209.644; DIRJXXLRJXTDMP; [M+H]+; Cordycepin, N(1)-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -237.376; NFFADTLTYRNKIN; [M+H]+; N(6)-Adenosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -237.614; BCSLVBZWCFTDPK; [M+H]+; ACMC-20bvvy
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.720; SBSBAPPUZRZYRV; [M+H]+; 8-Amino-3-D-ribofuranosyl-1,2,4-triazolo(4,3-a)pyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -248.244; PPLSURAOXNSSRH; [M+H]+; 2''-Amino-2''-deoxyinosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.020; SBQDZMTWLNGLQA; [M+H]+; Imidazo[1,2-a]-1,3,5-triazin-4(8H)-one, 2-amino-8-(2-deoxy-b-D-erythro-pentofuranosyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.637; BXQVVDJZCDTBBB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.482; VSHBWHHMEGOQNG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -292.835; IHYVWNRKXGTLCO; [M+H]+; N-D-Gluconoyl-beta-alanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -299.663; KBHMEHLJSZMEMI; [M+H]+; Formycin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -302.338; HGTOXWOVJAONKK; [M+H]+; O-Mannopyranosylserine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -305.231; URLLHQGMXWMBTR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -312.384; KUVQLWYPNUQGDT; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -314.676; JDJSHLXEHWCLEP; [M+H]+; Miserotoxin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.507; GRAIAQOAALQBTB; [M+H]+; 2''-Azido-2'',3''-dideoxythymidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -318.622; DOBVUNYQLACHMP; [M+H]+; (2S,3R,4S,5R)-2-(4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -321.745; BQINXKOTJQCISL; [M+H]+; 5-amino-3,5-dideoxynon-2-ulosonic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -323.725; NBXXOOCDYRGSOJ; [M+H]+; N-D-Gluconoyl-L-alanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.981; HBOMLICNUCNMMY; [M+H]+; Azitidin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -339.509; GRNUVTSRBRIYIO; [M+H]+; Prestwick0_000333
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -343.412; DMHAXLGAKQREIL; [M+H]+; Acyclovir Acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -369.229; CERZMXAJYMMUDR; [M+H]+; O-sialate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -458.644; UTJZDXBVQJNTHL; [M+H]+; 1-Me-5(3-Az-ddribo)T
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -502.463; JBGNSGHDTKKNKE; [M+H]+; 2-[(2,4-dimethoxyphenyl)methylideneamino]-1-nitroguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -566.489; ZCGXVDFOMRHQOX; [M+H]+; 3-amino-4-nitro-6,6-bis(prop-2-enyl)-1H-1,2,4-triazepine-5,7-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.684; OIRDTQYFTABQOQ; [M+H]+; Adenocor
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Adenosine, OIRDTQYFTABQOQ-KQYNXXCUSA-N; Matching to 74 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (3), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000050;HMDB0014340;
CH$NAME: Adenosine
CH$NAME: (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C10H13N5O4
CH$EXACT_MASS: 267.096754
CH$SMILES: C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N
CH$IUPAC: InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
CH$LINK: CHEBI CHEBI:16335
CH$LINK: HMDB HMDB0000050
CH$LINK: INCHIKEY OIRDTQYFTABQOQ-KQYNXXCUSA-N
CH$LINK: PUBCHEM CID:60961
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.996
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 268.104118
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-0900000000-43d5eca95e1a50f55212
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0180365 3.2230 55.018744 1.4541 0.75 0.9018 22 f{C3H3O1}/3.55ppm,p-C7H11N5O3
  57.0336985 4.7887 57.034415 1.2975 0.73 0.9654 23 f{C3H5O1}/3.64ppm,p-C7H9N5O3
  57.0700216 5.5957 57.070738 1.0513 3.56 0.4182 21 f{C4H9}/2.54ppm,p-C6H5N5O4
  69.0335306 2.5701 69.034274 1.2747 0.70 0.8972 22 f{C4H5O1}/0.57ppm,p-C6H9N5O3
  73.0284366 2.3203 73.029179 1.2324 0.37 0.9561 19 f{C3H5O2}/0.42ppm,p-C7H9N5O2
  85.0283690 3.5271 85.029081 1.0702 1.01 0.9221 22 f{C4H5O2}/-0.43ppm,p-C6H9N5O2
  94.0398878 4.0641 94.040548 1.0102 0.77 0.9605 23 f{C4H4N3}/-0.91ppm,p-C6H10N2O4
  119.0351643 9.3322 119.035613 0.9661 1.02 0.9842 23 f{C5H3N4}/-0.49ppm,p-C5H11N1O4
  136.0618326 999.0000 136.062096 0.3307 0.00 0.9991 24 f{C7H8N2O1}/-9.42ppm,p-C3H6N3O3
  137.0450027 3.2087 137.045269 1.3207 0.58 0.9484 18 f{C5H5N4O1}/-5.72ppm,p-C5H9N1O3
  137.0662600 36.8333 137.066526 0.9193 2.53 0.9965 24 ?
  268.1038882 63.4974 268.104272 0.3767 3.42 1.0000 24 f{C10H14N5O4}/-0.53ppm,p
  269.1072731 5.7416 269.107658 1.4046 0.89 0.9902 17 ?
PK$NUM_PEAK: 13
PK$PEAK: m/z int. rel.int.
  55.018036 3.22 3
  57.033698 4.79 4
  57.070022 5.60 5
  69.033531 2.57 2
  73.028437 2.32 2
  85.028369 3.53 3
  94.039888 4.06 4
  119.035164 9.33 9
  136.061833 999.00 999
  137.045003 3.21 3
  137.066260 36.83 36
  268.103888 63.50 63
  269.107273 5.74 5
//
